Respiratory News and Research

RSS

Could a tuna-derived protein inhibit SARS-CoV-2?

A recent study in the journal Food Chemistry draws attention to the need for finding nutritional supplements with potential SARS-CoV-2 inhibition effects in the wake of the COVID-19 pandemic.

19 Apr 2021

Plant-derived compound isorhamnetin may have antiviral potential against SARS-CoV-2

The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.

19 Apr 2021

SARS-CoV-2 nucleoprotein can trigger α-synuclein amyloid fibril formation

A new study, released as a preprint on the bioRxiv* server, casts some light on the pathogenesis of acute and subacute neurological complications associated with COVID-19.

19 Apr 2021

Study assess prevalence of SARS-CoV-2 in England after third national lockdown

In a new study, the REACT-1 research group offer their findings on the rate of SARS-CoV-2 infection in England after the country went into a third national lockdown. Their findings show a 60% reduction of incidence from their previous round of surveillance.

19 Apr 2021

Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks

A recent study by researchers at the University of British Columbia (B.C.) shows that the benefits of continuing the COVID-19 vaccine of front-line workers with the AstraZeneca vaccine outweigh the increased risk of prothrombotic thrombocytopenia.

19 Apr 2021

U.S. vaccinates 131 million Americans against SARS-CoV-2

The country has jabbed over 131 million Americans (39.5% of the Total Population), including over 84 million who have been fully vaccinated (25.4%% of the Total Population).

19 Apr 2021

Humans versus viruses - Can we avoid extinction in near future?

Expert argues that human-caused changes to the environment can lead to the emergence of pathogens, not only from outside but also from our own microbiome, which can pave the way for large-scale destruction of humans and even our extinction.

19 Apr 2021

Obesity, hypertension and smoking linked to lower vaccine-induced antibody production against SARS-CoV-2

In a recent study posted to the medRxiv preprint server, a research group from Italy has demonstrated that the antibody response can be blunted in subjects with certain risk factors shortly after the second dose of mRNA vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 Apr 2021

Research looks at SARS-CoV-2 transmission from people to pets

A large team of researchers from the US demonstrated that pets with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) likely acquired the putative virus from humans. This suggests that human-animal infection may actually occur much more frequently than previously thought – implying that infected individuals should limit their contact with animals.

18 Apr 2021

Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines

Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

18 Apr 2021

Overwhelming evidence SARS-CoV-2 is airborne

Researchers in the United States, UK, and Canada have published a commentary challenging the suggestion that the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may not be airborne.

18 Apr 2021

Past COVID-19 infection does not completely protect against reinfection in young people

Although antibodies induced by SARS-CoV-2 infection are largely protective, they do not completely protect against reinfection in young people, as evidenced through a longitudinal, prospective study of more than 3,000 young, healthy members of the US Marines Corps conducted by researchers at the Icahn School of Medicine at Mount Sinai and the Naval Medical Research Center, published April 15 in The Lancet Respiratory Medicine.

17 Apr 2021

SARS-CoV-2 does not directly infect the brain but can inflict neurological damage

SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain but can still inflict significant neurological damage, according to a new study from neuropathologists, neurologists, and neuroradiologists at Columbia University Vagelos College of Physicians and Surgeons.

17 Apr 2021

Ask KHN-Politifact: I’ve recovered from Covid. Why do i still have to mask up?

More than 120 million Americans have joined arguably the most sought-after club on Earth: those immunized against the coronavirus.

16 Apr 2021

Researchers identify risk factors for SARS-CoV-2 reinfection

A team of scientists from the Capital Medical University and Peking University, China, has recently explored the factors responsible for the reactivation of SARS-CoV-2 infection among individuals who have recently recovered from COVID-19. The findings reveal that individuals with lower lymphocyte count or with two or fewer symptoms during the first COVID-19 episode are at higher risk of recurrent infection.

16 Apr 2021

Numerous agents with anti-SARS-CoV-2 potential discovered with crystallographic screening

An international team of researchers focused on the macrodomain part of the non-structural protein 3 (Nsp3) gene product that SARS-CoV-2 uses to overturn the host cell’s natural antiviral response. The team provided a template that can help develop novel antivirals that are direct-acting and can combat the current pandemic.

16 Apr 2021

SARS-CoV-2 can alter bone marrow macrophage (BMM)-to-osteoclast differentiation, study finds

Now, a team of researchers in China and Australia has shown that SARS-CoV-2 infection can affect bone marrow macrophage (BMM)-to-osteoclast differentiation, which may impact the skeletal system.

16 Apr 2021

New and more effective treatment for Pompe disease

Rare diseases are sometimes the most difficult to treat because of a lack of research and fewer participants to study.

16 Apr 2021

COVID-19 vaccination of lactating mothers elicits specific IgA antibodies in breast milk

A new study, released on the medRxiv* preprint server, examines the presence of SARS-CoV-2-specific IgA in human milk and its association with the protection of breastfed infants against the disease.

16 Apr 2021

Curcumin nanosystems could be powerful COVID-19 therapeutics

With new variants of SARS-CoV-2 emerging, the COVID-19 pandemic is far from over. While the global vaccine rollout has moved at an impressive speed, the search for new safe, effective, and targeted therapies is still on. Now, a new study reviews the potential for curcumin, a natural alkaloid derived from turmeric, and nanosystems to treat COVID-19.

16 Apr 2021

Respiratory News and Research

Could a tuna-derived protein inhibit SARS-CoV-2?

Plant-derived compound isorhamnetin may have antiviral potential against SARS-CoV-2

SARS-CoV-2 nucleoprotein can trigger α-synuclein amyloid fibril formation

Study assess prevalence of SARS-CoV-2 in England after third national lockdown

Research says benefits of continuing immunization of front-line workers in BC with AstraZeneca vaccine far outweigh risks

U.S. vaccinates 131 million Americans against SARS-CoV-2

Humans versus viruses - Can we avoid extinction in near future?

Obesity, hypertension and smoking linked to lower vaccine-induced antibody production against SARS-CoV-2

Research looks at SARS-CoV-2 transmission from people to pets

Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines

Overwhelming evidence SARS-CoV-2 is airborne

Past COVID-19 infection does not completely protect against reinfection in young people

SARS-CoV-2 does not directly infect the brain but can inflict neurological damage

Ask KHN-Politifact: I’ve recovered from Covid. Why do i still have to mask up?

Researchers identify risk factors for SARS-CoV-2 reinfection

Numerous agents with anti-SARS-CoV-2 potential discovered with crystallographic screening

SARS-CoV-2 can alter bone marrow macrophage (BMM)-to-osteoclast differentiation, study finds

New and more effective treatment for Pompe disease

COVID-19 vaccination of lactating mothers elicits specific IgA antibodies in breast milk

Curcumin nanosystems could be powerful COVID-19 therapeutics

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News